Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neuroblastoma Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Combination Chemotherapy
1.2.3 Monoclonal Antibody Therapy
1.2.4 Vaccine Therapy
1.2.5 Chimeric Antigen Receptor T-Cell Immunotherapy
1.2.6 Oncolytic Virus Therapy
1.3 Market by Application
1.3.1 Global Neuroblastoma Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neuroblastoma Treatment Market Perspective (2018-2029)
2.2 Global Neuroblastoma Treatment Growth Trends by Region
2.2.1 Neuroblastoma Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Neuroblastoma Treatment Historic Market Size by Region (2018-2024)
2.2.3 Neuroblastoma Treatment Forecasted Market Size by Region (2024-2029)
2.3 Neuroblastoma Treatment Market Dynamics
2.3.1 Neuroblastoma Treatment Industry Trends
2.3.2 Neuroblastoma Treatment Market Drivers
2.3.3 Neuroblastoma Treatment Market Challenges
2.3.4 Neuroblastoma Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Neuroblastoma Treatment by Players
3.1.1 Global Neuroblastoma Treatment Revenue by Players (2018-2024)
3.1.2 Global Neuroblastoma Treatment Revenue Market Share by Players (2018-2024)
3.2 Global Neuroblastoma Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Neuroblastoma Treatment, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Neuroblastoma Treatment Market Concentration Ratio
3.4.1 Global Neuroblastoma Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neuroblastoma Treatment Revenue in 2022
3.5 Global Key Players of Neuroblastoma Treatment Head office and Area Served
3.6 Global Key Players of Neuroblastoma Treatment, Product and Application
3.7 Global Key Players of Neuroblastoma Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Neuroblastoma Treatment Breakdown Data by Type
4.1 Global Neuroblastoma Treatment Historic Market Size by Type (2018-2024)
4.2 Global Neuroblastoma Treatment Forecasted Market Size by Type (2024-2029)
5 Neuroblastoma Treatment Breakdown Data by Application
5.1 Global Neuroblastoma Treatment Historic Market Size by Application (2018-2024)
5.2 Global Neuroblastoma Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Neuroblastoma Treatment Market Size (2018-2029)
6.2 North America Neuroblastoma Treatment Market Size by Type
6.2.1 North America Neuroblastoma Treatment Market Size by Type (2018-2024)
6.2.2 North America Neuroblastoma Treatment Market Size by Type (2024-2029)
6.2.3 North America Neuroblastoma Treatment Market Share by Type (2018-2029)
6.3 North America Neuroblastoma Treatment Market Size by Application
6.3.1 North America Neuroblastoma Treatment Market Size by Application (2018-2024)
6.3.2 North America Neuroblastoma Treatment Market Size by Application (2024-2029)
6.3.3 North America Neuroblastoma Treatment Market Share by Application (2018-2029)
6.4 North America Neuroblastoma Treatment Market Size by Country
6.4.1 North America Neuroblastoma Treatment Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Neuroblastoma Treatment Market Size by Country (2018-2024)
6.4.3 North America Neuroblastoma Treatment Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Neuroblastoma Treatment Market Size (2018-2029)
7.2 Europe Neuroblastoma Treatment Market Size by Type
7.2.1 Europe Neuroblastoma Treatment Market Size by Type (2018-2024)
7.2.2 Europe Neuroblastoma Treatment Market Size by Type (2024-2029)
7.2.3 Europe Neuroblastoma Treatment Market Share by Type (2018-2029)
7.3 Europe Neuroblastoma Treatment Market Size by Application
7.3.1 Europe Neuroblastoma Treatment Market Size by Application (2018-2024)
7.3.2 Europe Neuroblastoma Treatment Market Size by Application (2024-2029)
7.3.3 Europe Neuroblastoma Treatment Market Share by Application (2018-2029)
7.4 Europe Neuroblastoma Treatment Market Size by Country
7.4.1 Europe Neuroblastoma Treatment Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Neuroblastoma Treatment Market Size by Country (2018-2024)
7.4.3 Europe Neuroblastoma Treatment Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Neuroblastoma Treatment Market Size (2018-2029)
8.2 China Neuroblastoma Treatment Market Size by Type
8.2.1 China Neuroblastoma Treatment Market Size by Type (2018-2024)
8.2.2 China Neuroblastoma Treatment Market Size by Type (2024-2029)
8.2.3 China Neuroblastoma Treatment Market Share by Type (2018-2029)
8.3 China Neuroblastoma Treatment Market Size by Application
8.3.1 China Neuroblastoma Treatment Market Size by Application (2018-2024)
8.3.2 China Neuroblastoma Treatment Market Size by Application (2024-2029)
8.3.3 China Neuroblastoma Treatment Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Neuroblastoma Treatment Market Size (2018-2029)
9.2 Asia Neuroblastoma Treatment Market Size by Type
9.2.1 Asia Neuroblastoma Treatment Market Size by Type (2018-2024)
9.2.2 Asia Neuroblastoma Treatment Market Size by Type (2024-2029)
9.2.3 Asia Neuroblastoma Treatment Market Share by Type (2018-2029)
9.3 Asia Neuroblastoma Treatment Market Size by Application
9.3.1 Asia Neuroblastoma Treatment Market Size by Application (2018-2024)
9.3.2 Asia Neuroblastoma Treatment Market Size by Application (2024-2029)
9.3.3 Asia Neuroblastoma Treatment Market Share by Application (2018-2029)
9.4 Asia Neuroblastoma Treatment Market Size by Region
9.4.1 Asia Neuroblastoma Treatment Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Neuroblastoma Treatment Market Size by Region (2018-2024)
9.4.3 Asia Neuroblastoma Treatment Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Neuroblastoma Treatment Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Neuroblastoma Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America Neuroblastoma Treatment Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Neuroblastoma Treatment Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Neuroblastoma Treatment Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Neuroblastoma Treatment Market Size by Application
10.3.1 Middle East, Africa, and Latin America Neuroblastoma Treatment Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Neuroblastoma Treatment Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Neuroblastoma Treatment Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Neuroblastoma Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America Neuroblastoma Treatment Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Neuroblastoma Treatment Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Neuroblastoma Treatment Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Seattle Children’s
11.1.1 Seattle Children’s Company Details
11.1.2 Seattle Children’s Business Overview
11.1.3 Seattle Children’s Neuroblastoma Treatment Introduction
11.1.4 Seattle Children’s Revenue in Neuroblastoma Treatment Business (2018-2024)
11.1.5 Seattle Children’s Recent Developments
11.2 CureSearch
11.2.1 CureSearch Company Details
11.2.2 CureSearch Business Overview
11.2.3 CureSearch Neuroblastoma Treatment Introduction
11.2.4 CureSearch Revenue in Neuroblastoma Treatment Business (2018-2024)
11.2.5 CureSearch Recent Developments
11.3 Texas Children’s
11.3.1 Texas Children’s Company Details
11.3.2 Texas Children’s Business Overview
11.3.3 Texas Children’s Neuroblastoma Treatment Introduction
11.3.4 Texas Children’s Revenue in Neuroblastoma Treatment Business (2018-2024)
11.3.5 Texas Children’s Recent Developments
11.4 NANT
11.4.1 NANT Company Details
11.4.2 NANT Business Overview
11.4.3 NANT Neuroblastoma Treatment Introduction
11.4.4 NANT Revenue in Neuroblastoma Treatment Business (2018-2024)
11.4.5 NANT Recent Developments
11.5 Sino Biopharmaceutical
11.5.1 Sino Biopharmaceutical Company Details
11.5.2 Sino Biopharmaceutical Business Overview
11.5.3 Sino Biopharmaceutical Neuroblastoma Treatment Introduction
11.5.4 Sino Biopharmaceutical Revenue in Neuroblastoma Treatment Business (2018-2024)
11.5.5 Sino Biopharmaceutical Recent Developments
11.6 Jiangsu Hengrui Medicine Co.,Ltd.
11.6.1 Jiangsu Hengrui Medicine Co.,Ltd. Company Details
11.6.2 Jiangsu Hengrui Medicine Co.,Ltd. Business Overview
11.6.3 Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Introduction
11.6.4 Jiangsu Hengrui Medicine Co.,Ltd. Revenue in Neuroblastoma Treatment Business (2018-2024)
11.6.5 Jiangsu Hengrui Medicine Co.,Ltd. Recent Developments
11.7 Fosun Pharmaceutical
11.7.1 Fosun Pharmaceutical Company Details
11.7.2 Fosun Pharmaceutical Business Overview
11.7.3 Fosun Pharmaceutical Neuroblastoma Treatment Introduction
11.7.4 Fosun Pharmaceutical Revenue in Neuroblastoma Treatment Business (2018-2024)
11.7.5 Fosun Pharmaceutical Recent Developments
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Novartis Business Overview
11.8.3 Novartis Neuroblastoma Treatment Introduction
11.8.4 Novartis Revenue in Neuroblastoma Treatment Business (2018-2024)
11.8.5 Novartis Recent Developments
11.9 Juno Therapeutics
11.9.1 Juno Therapeutics Company Details
11.9.2 Juno Therapeutics Business Overview
11.9.3 Juno Therapeutics Neuroblastoma Treatment Introduction
11.9.4 Juno Therapeutics Revenue in Neuroblastoma Treatment Business (2018-2024)
11.9.5 Juno Therapeutics Recent Developments
11.10 Kite Pharma
11.10.1 Kite Pharma Company Details
11.10.2 Kite Pharma Business Overview
11.10.3 Kite Pharma Neuroblastoma Treatment Introduction
11.10.4 Kite Pharma Revenue in Neuroblastoma Treatment Business (2018-2024)
11.10.5 Kite Pharma Recent Developments
11.11 Adaptimmune
11.11.1 Adaptimmune Company Details
11.11.2 Adaptimmune Business Overview
11.11.3 Adaptimmune Neuroblastoma Treatment Introduction
11.11.4 Adaptimmune Revenue in Neuroblastoma Treatment Business (2018-2024)
11.11.5 Adaptimmune Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Neuroblastoma Treatment Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Combination Chemotherapy
Table 3. Key Players of Monoclonal Antibody Therapy
Table 4. Key Players of Vaccine Therapy
Table 5. Key Players of Chimeric Antigen Receptor T-Cell Immunotherapy
Table 6. Key Players of Oncolytic Virus Therapy
Table 7. Global Neuroblastoma Treatment Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 8. Global Neuroblastoma Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Neuroblastoma Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 10. Global Neuroblastoma Treatment Market Share by Region (2018-2024)
Table 11. Global Neuroblastoma Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Neuroblastoma Treatment Market Share by Region (2024-2029)
Table 13. Neuroblastoma Treatment Market Trends
Table 14. Neuroblastoma Treatment Market Drivers
Table 15. Neuroblastoma Treatment Market Challenges
Table 16. Neuroblastoma Treatment Market Restraints
Table 17. Global Neuroblastoma Treatment Revenue by Players (2018-2024) & (US$ Million)
Table 18. Global Neuroblastoma Treatment Revenue Share by Players (2018-2024)
Table 19. Global Top Neuroblastoma Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuroblastoma Treatment as of 2022)
Table 20. Global Neuroblastoma Treatment Industry Ranking 2021 VS 2022 VS 2024
Table 21. Global 5 Largest Players Market Share by Neuroblastoma Treatment Revenue (CR5 and HHI) & (2018-2024)
Table 22. Global Key Players of Neuroblastoma Treatment, Headquarters and Area Served
Table 23. Global Key Players of Neuroblastoma Treatment, Product and Application
Table 24. Global Key Players of Neuroblastoma Treatment, Product and Application
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Neuroblastoma Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 27. Global Neuroblastoma Treatment Revenue Market Share by Type (2018-2024)
Table 28. Global Neuroblastoma Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Neuroblastoma Treatment Revenue Market Share by Type (2024-2029)
Table 30. Global Neuroblastoma Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 31. Global Neuroblastoma Treatment Revenue Share by Application (2018-2024)
Table 32. Global Neuroblastoma Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Neuroblastoma Treatment Revenue Share by Application (2024-2029)
Table 34. North America Neuroblastoma Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 35. North America Neuroblastoma Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 36. North America Neuroblastoma Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 37. North America Neuroblastoma Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 38. North America Neuroblastoma Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 39. North America Neuroblastoma Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 40. North America Neuroblastoma Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 41. Europe Neuroblastoma Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 42. Europe Neuroblastoma Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 43. Europe Neuroblastoma Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 44. Europe Neuroblastoma Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 45. Europe Neuroblastoma Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Europe Neuroblastoma Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 47. Europe Neuroblastoma Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 48. China Neuroblastoma Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 49. China Neuroblastoma Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 50. China Neuroblastoma Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 51. China Neuroblastoma Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 52. Asia Neuroblastoma Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 53. Asia Neuroblastoma Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 54. Asia Neuroblastoma Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 55. Asia Neuroblastoma Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 56. Asia Neuroblastoma Treatment Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 57. Asia Neuroblastoma Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 58. Asia Neuroblastoma Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Neuroblastoma Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Neuroblastoma Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Neuroblastoma Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Neuroblastoma Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Neuroblastoma Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 64. Middle East, Africa, and Latin America Neuroblastoma Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Neuroblastoma Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 66. Seattle Children’s Company Details
Table 67. Seattle Children’s Business Overview
Table 68. Seattle Children’s Neuroblastoma Treatment Product
Table 69. Seattle Children’s Revenue in Neuroblastoma Treatment Business (2018-2024) & (US$ Million)
Table 70. Seattle Children’s Recent Developments
Table 71. CureSearch Company Details
Table 72. CureSearch Business Overview
Table 73. CureSearch Neuroblastoma Treatment Product
Table 74. CureSearch Revenue in Neuroblastoma Treatment Business (2018-2024) & (US$ Million)
Table 75. CureSearch Recent Developments
Table 76. Texas Children’s Company Details
Table 77. Texas Children’s Business Overview
Table 78. Texas Children’s Neuroblastoma Treatment Product
Table 79. Texas Children’s Revenue in Neuroblastoma Treatment Business (2018-2024) & (US$ Million)
Table 80. Texas Children’s Recent Developments
Table 81. NANT Company Details
Table 82. NANT Business Overview
Table 83. NANT Neuroblastoma Treatment Product
Table 84. NANT Revenue in Neuroblastoma Treatment Business (2018-2024) & (US$ Million)
Table 85. NANT Recent Developments
Table 86. Sino Biopharmaceutical Company Details
Table 87. Sino Biopharmaceutical Business Overview
Table 88. Sino Biopharmaceutical Neuroblastoma Treatment Product
Table 89. Sino Biopharmaceutical Revenue in Neuroblastoma Treatment Business (2018-2024) & (US$ Million)
Table 90. Sino Biopharmaceutical Recent Developments
Table 91. Jiangsu Hengrui Medicine Co.,Ltd. Company Details
Table 92. Jiangsu Hengrui Medicine Co.,Ltd. Business Overview
Table 93. Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Product
Table 94. Jiangsu Hengrui Medicine Co.,Ltd. Revenue in Neuroblastoma Treatment Business (2018-2024) & (US$ Million)
Table 95. Jiangsu Hengrui Medicine Co.,Ltd. Recent Developments
Table 96. Fosun Pharmaceutical Company Details
Table 97. Fosun Pharmaceutical Business Overview
Table 98. Fosun Pharmaceutical Neuroblastoma Treatment Product
Table 99. Fosun Pharmaceutical Revenue in Neuroblastoma Treatment Business (2018-2024) & (US$ Million)
Table 100. Fosun Pharmaceutical Recent Developments
Table 101. Novartis Company Details
Table 102. Novartis Business Overview
Table 103. Novartis Neuroblastoma Treatment Product
Table 104. Novartis Revenue in Neuroblastoma Treatment Business (2018-2024) & (US$ Million)
Table 105. Novartis Recent Developments
Table 106. Juno Therapeutics Company Details
Table 107. Juno Therapeutics Business Overview
Table 108. Juno Therapeutics Neuroblastoma Treatment Product
Table 109. Juno Therapeutics Revenue in Neuroblastoma Treatment Business (2018-2024) & (US$ Million)
Table 110. Juno Therapeutics Recent Developments
Table 111. Kite Pharma Company Details
Table 112. Kite Pharma Business Overview
Table 113. Kite Pharma Neuroblastoma Treatment Product
Table 114. Kite Pharma Revenue in Neuroblastoma Treatment Business (2018-2024) & (US$ Million)
Table 115. Kite Pharma Recent Developments
Table 116. Adaptimmune Company Details
Table 117. Adaptimmune Business Overview
Table 118. Adaptimmune Neuroblastoma Treatment Product
Table 119. Adaptimmune Revenue in Neuroblastoma Treatment Business (2018-2024) & (US$ Million)
Table 120. Adaptimmune Recent Developments
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neuroblastoma Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Neuroblastoma Treatment Market Share by Type: 2022 VS 2029
Figure 3. Combination Chemotherapy Features
Figure 4. Monoclonal Antibody Therapy Features
Figure 5. Vaccine Therapy Features
Figure 6. Chimeric Antigen Receptor T-Cell Immunotherapy Features
Figure 7. Oncolytic Virus Therapy Features
Figure 8. Global Neuroblastoma Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Neuroblastoma Treatment Market Share by Application: 2022 VS 2029
Figure 10. Hospitals Case Studies
Figure 11. Clinics Case Studies
Figure 12. Others Case Studies
Figure 13. Neuroblastoma Treatment Report Years Considered
Figure 14. Global Neuroblastoma Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Neuroblastoma Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Neuroblastoma Treatment Market Share by Region: 2022 VS 2029
Figure 17. Global Neuroblastoma Treatment Market Share by Players in 2022
Figure 18. Global Top Neuroblastoma Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuroblastoma Treatment as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Neuroblastoma Treatment Revenue in 2022
Figure 20. North America Neuroblastoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Neuroblastoma Treatment Market Share by Type (2018-2029)
Figure 22. North America Neuroblastoma Treatment Market Share by Application (2018-2029)
Figure 23. North America Neuroblastoma Treatment Market Share by Country (2018-2029)
Figure 24. United States Neuroblastoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Canada Neuroblastoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Neuroblastoma Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 27. Europe Neuroblastoma Treatment Market Share by Type (2018-2029)
Figure 28. Europe Neuroblastoma Treatment Market Share by Application (2018-2029)
Figure 29. Europe Neuroblastoma Treatment Market Share by Country (2018-2029)
Figure 30. Germany Neuroblastoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. France Neuroblastoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. U.K. Neuroblastoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Italy Neuroblastoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Russia Neuroblastoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Nordic Countries Neuroblastoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. China Neuroblastoma Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 37. China Neuroblastoma Treatment Market Share by Type (2018-2029)
Figure 38. China Neuroblastoma Treatment Market Share by Application (2018-2029)
Figure 39. Asia Neuroblastoma Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 40. Asia Neuroblastoma Treatment Market Share by Type (2018-2029)
Figure 41. Asia Neuroblastoma Treatment Market Share by Application (2018-2029)
Figure 42. Asia Neuroblastoma Treatment Market Share by Region (2018-2029)
Figure 43. Japan Neuroblastoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. South Korea Neuroblastoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. China Taiwan Neuroblastoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Southeast Asia Neuroblastoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. India Neuroblastoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Australia Neuroblastoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Neuroblastoma Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Neuroblastoma Treatment Market Share by Type (2018-2029)
Figure 51. Middle East, Africa, and Latin America Neuroblastoma Treatment Market Share by Application (2018-2029)
Figure 52. Middle East, Africa, and Latin America Neuroblastoma Treatment Market Share by Country (2018-2029)
Figure 53. Brazil Neuroblastoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Mexico Neuroblastoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Turkey Neuroblastoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Saudi Arabia Neuroblastoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Israel Neuroblastoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. GCC Countries Neuroblastoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 59. Seattle Children’s Revenue Growth Rate in Neuroblastoma Treatment Business (2018-2024)
Figure 60. CureSearch Revenue Growth Rate in Neuroblastoma Treatment Business (2018-2024)
Figure 61. Texas Children’s Revenue Growth Rate in Neuroblastoma Treatment Business (2018-2024)
Figure 62. NANT Revenue Growth Rate in Neuroblastoma Treatment Business (2018-2024)
Figure 63. Sino Biopharmaceutical Revenue Growth Rate in Neuroblastoma Treatment Business (2018-2024)
Figure 64. Jiangsu Hengrui Medicine Co.,Ltd. Revenue Growth Rate in Neuroblastoma Treatment Business (2018-2024)
Figure 65. Fosun Pharmaceutical Revenue Growth Rate in Neuroblastoma Treatment Business (2018-2024)
Figure 66. Novartis Revenue Growth Rate in Neuroblastoma Treatment Business (2018-2024)
Figure 67. Juno Therapeutics Revenue Growth Rate in Neuroblastoma Treatment Business (2018-2024)
Figure 68. Kite Pharma Revenue Growth Rate in Neuroblastoma Treatment Business (2018-2024)
Figure 69. Adaptimmune Revenue Growth Rate in Neuroblastoma Treatment Business (2018-2024)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed